Fast Delivery

Safe and Secured Payments

Free Shipping on Orders Above 2000🎁

Search

BPc 157 Pure, 30 Capsules, Delayed Release

BPC-157 Pure Peptide – Delayed Release Capsules for Research-Informed Tissue and Gut Health Support

₹11,000

Why Choose Arka Products

Quality Assurance

Clinically Proven

Transparent Ingredients

Customer Satisfaction

Integrative Peptides BPC-157 Pure Delayed Release Capsules contain BPC-157, a synthetic peptide consisting of 15 amino acids that has been studied primarily in preclinical research. Investigations have explored its potential effects on tissue repair, gastrointestinal integrity, inflammation, and other biological processes.

The delayed-release capsule format is intended to release its contents later in the digestive tract. However, the extent of absorption, bioavailability, and clinical benefits of oral BPC-157 in humans have not been adequately established.

BPC-157 is not an established treatment for gastrointestinal disorders, musculoskeletal injuries, cardiovascular conditions, neurological conditions, or medication-related toxicity. Consult a qualified healthcare professional before considering this product.

Important: Human safety, effective dosage, long-term effects, and potential drug interactions remain insufficiently characterized. Do not use this product as a substitute for prescribed medical treatment.

Active ingredient: BPC-157 (Body Protection Compound-157), a synthetic peptide consisting of 15 amino acids.

Other ingredients: Please refer to the manufacturer’s label for the complete excipient and capsule composition.

  • Research into tissue repair: BPC-157 is being investigated for its potential role in tissue healing in preclinical studies.
  • Gastrointestinal research: Studied for possible effects on gastrointestinal tissue integrity and healing.
  • Inflammation research: Investigated for potential effects on inflammatory pathways.
  • Musculoskeletal research: Preclinical studies have explored its possible effects on tendons, ligaments, muscles, and other connective tissues.
  • Delayed-release format: Designed to delay the release of the capsule contents in the digestive tract.

Use only if the product is legally authorized for the intended purpose and under appropriate professional guidance. Follow the verified product label and the advice of a qualified healthcare professional. Do not assume that a dosage used in animal studies is appropriate for humans.

There is no established, evidence-based indication or dosing schedule for BPC-157 in humans. Seek medical advice before considering use for gastrointestinal symptoms, injuries, inflammation, or other health concerns.

No specific patient group has been established for whom BPC-157 is proven safe and effective. Any consideration of use should be reviewed by a qualified healthcare professional, taking into account the individual’s health status and applicable regulations.

  • Pregnant or breastfeeding individuals.
  • Children and adolescents.
  • Individuals with known hypersensitivity to any ingredient.
  • Individuals with significant medical conditions or those taking prescription medicines, unless a qualified healthcare professional has assessed the risks.
  • Anyone considering BPC-157 as a replacement for prescribed treatment or urgent medical care.

Because human safety data are limited, these precautions do not represent a complete list of contraindications.

Related Products